Telemedicine gone, a shipping ban on flower, mandatory in-person doctor visits. Germany's MedCanG tightening comes wrapped in the language of "drug safety". But honestly, who does this thing actually hit? Here's the straight talk.
Table of Contents
Quick note for our international readers: This is about the situation in Germany. Rules for medical cannabis differ from country to country. Europe overview is further down.
What it's about
There's one line from the expert hearing in the Bundestag that stuck: the shipping ban serves patient protection less than it serves a targeted strike against telemedicine providers. Experts call it Lex Telemedicine. And that's the real question behind the whole reform.
Since 2024, medical cannabis in Germany was easy to get: video consultation, prescription, online pharmacy ships it to your door. For many people, especially the chronically ill and those in rural areas, this online cannabis prescription was their only real access in the first place. The MedCanG amendment now reverses that. Three things change: first prescriptions only after a real in-person doctor visit, a shipping ban on flower (only available through your local pharmacy or its courier service now), and for repeat prescriptions you have to show up regularly again. The ministry's reasoning: prescribing practice has been too lax.
And when does it kick in? The most-googled question right now, and the honest answer: it depends on the final readings in the Bundestag. Until the thing is published in the Federal Law Gazette, the old rules apply. So for you: check the current status before making any decision.
To be fair, the other side has a point
It'd be cheap to just write this off as harassment. In-person advice genuinely has value, a pharmacy explains THC and CBD content and interactions to you. There was also real overgrowth, some platforms prescribed with an obviously low bar. And quality is easier to control on site. All legitimate. The only question is: does that justify the means?
Why everyone calls it "Lex Telemedicine"
Here's where it gets uncomfortable. The harshest criticism comes from lawyers, not activists. Their point: other controlled substances may still be shipped. A shipping ban specifically for cannabis flower is therefore hard to justify cleanly. If the shipping route itself were the problem, it would have to be closed for comparable substances too. But it isn't. That smells strongly like it's not about the shipping, but about who runs it.
Then there's occupational freedom (Article 12 of the German Constitution): a ban that effectively favours only brick-and-mortar pharmacies and dries up an entire digital segment needs a damn good reason. And even industry associations that want to crack down on dodgy platforms say a blanket ban overshoots the target. You could go after the shady providers specifically instead of cutting the whole model.
Who it really hits
The bill isn't paid by the grey-area platforms, but by people who were never the problem. People in rural areas, for whom the nearest prescribing doctor is miles away. Chronically ill people, for whom every forced appointment is a real hurdle, even though a video call once or twice a year would comfortably do. And in the end, supply security itself, because whoever can't get through legally anymore ends up back on the black market. So exactly the opposite of what the reform wants.
Over 58,000 people petitioned against it, and even within the coalition there's unrest, voices from the SPD don't want to approve the shipping ban in this form. When a law supposedly protects patients, but patients and parts of the governing coalition are up in arms against it, you're allowed to ask who it actually benefits.
Bottom line
Patient protection and the fight against junk prescriptions are legit. But a targeted strike against dodgy platforms would hit the problem. A blanket shipping ban hits something else: a business model, and the people who relied on it. Whoever wants to fight abuse can do it surgically. Whoever pulls out the sledgehammer shouldn't be surprised if the result looks less like patient protection and more like a Lex Telemedicine.
Cannabis legalisation in Europe: where things stand in 2026
Germany is not a special case. Unlike Canada or many US states, the EU to this day has not a single full retail market for recreational cannabis. The European model is more cautious, mostly home cultivation and non-commercial clubs:
- Germany (since 2024): possession, home cultivation and Cannabis Social Clubs allowed. Retail sale remains off limits.
- Malta (since 2021): first EU country with legal home cultivation and private possession.
- Luxembourg (since 2023): home cultivation of up to four plants per household, no sale.
- Czech Republic (since 1 January 2026): fresh framework with legal possession and home cultivation. The latest move.
- Netherlands: the old coffeeshop model, plus a pilot for a regulated supply chain since 2025.
- Switzerland: several state-approved pilot programmes.
- Most of Europe (France, Poland, UK, Austria): cannabis on medical prescription only, otherwise still strict.
The trend clearly points toward reform, but mostly via home cultivation rather than retail. And the German MedCanG story shows it doesn't only move forward.
⚠️ Legal notice (disclaimer)
This article is for information and educational purposes only and is not legal, medical or tax advice. All information reflects the status at the time of publication. Cannabis laws change quickly and sometimes at short notice, and proposals like the MedCanG amendment can still change during the process. We assume no liability for the accuracy or completeness of the content. Check the current legal situation before any decision and, if needed, seek advice from a doctor, pharmacy or legal counsel. Use of this information is at your own risk.
Consume clean, no matter how the laws go
One thing no reform changes: if you smoke, you don't want to inhale all the junk with it. That's exactly what our Hybrid Supreme Filters are for, with fiber caps and activated carbon. Lab-tested: 38% fewer harmful substances than conventional activated carbon filters without a fiber cap. No clogging, even in the cold, full flavour. Just smooth.
Trial pack via newsletter only. Free shipping from EUR 40 in AT and DE.
FAQ: Cannabis shipping ban & MedCanG
When does the cannabis shipping ban take effect in Germany?
There's no fixed date yet. The shipping ban is part of the MedCanG amendment, which still has to pass the final readings in the Bundestag. It only takes effect once the law is published in the Federal Law Gazette. Until then the existing legal situation applies. Check the current status before any decision.
What exactly changes with the MedCanG tightening?
Three things: first prescriptions are only issued after an in-person doctor visit, cannabis flower may no longer be shipped by post from online pharmacies (only local pharmacy or its courier service), and repeat prescriptions now require regular in-person appointments.
Is an online cannabis prescription still possible?
The purely telemedical first prescription is set to be dropped, meaning the first prescription needs real doctor contact. Telemedicine may continue to accompany ongoing treatment, but not initiate it. The exact framework depends on the final version of the law.
Why do lawyers call the whole thing "Lex Telemedicine"?
Because other controlled substances may still be shipped. A shipping ban specifically for cannabis flower is therefore hard to justify and looks less like patient protection and more like a targeted strike against telemedical online providers. Critics also see a possible interference with occupational freedom (Article 12 of the German Constitution).
Where does Germany stand on cannabis compared to Europe?
Since 2024 Germany has one of the more progressive frameworks with possession, home cultivation and Cannabis Social Clubs, but no retail sale. Malta, Luxembourg and, since 2026, the Czech Republic allow home cultivation and private possession. A full commercial retail market for recreational cannabis does not exist anywhere in the EU so far.
Share it if it got you fired up:
Sources
- Pharmazeutische Zeitung: Mail campaign against the cannabis shipping ban – pharmazeutische-zeitung.de
- Pharmazeutische Zeitung: The MedCanG and the "Struck" law – pharmazeutische-zeitung.de
- beck-aktuell: Tightening of the MedCanG meets criticism (Art. 12 GG) – beck-aktuell.de
- Gleiss Lutz: Cannabis legalisation update – ban on telemedical prescription – gleisslutz.com
- Summary of the Bundestag hearing on the MedCanG (14 Jan 2026) – metaller.de
- weed.de: Can partial legalisation be reversed? – weed.de
- The Cannigma: What Europe's 2026 legalisation data shows – cannigma.com
- Cannapio: Map of cannabis legalisation in Europe 2026 (EUDA data) – cannapio.com
